17:13 IST
NSE
Other Announcement
Astec Lifesciences Other Announcement
Astec LifeSciences confirmed nil deviation in the utilization of proceeds from its listed Non-Convertible Debentures for the quarter ended 30th June, 2026.
Astec Lifesciences Ltd
- Share price
- ₹748.20
- Market cap
- ₹1,667 Cr
- Revenue (annual)
- ₹448.1 Cr
- Net profit (annual)
- ₹-80.92 Cr
- P/E (TTM)
- -25.0×Sector 36.8×
- Promoter holding
- 71.96%-0.01% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Debt & Borrowing 12Price Movement Clarification 5Annual General Meeting 5Other Announcement 4Financial Results 4Employee Stock Options 4Board Meeting Outcome 4Management Change 3Results Update 2Fund Raise 1Board Meeting Date 1Annual Report 1
Time
4 announcements with these filters
14:38 IST
BSE
Other Announcement
Astec Lifesciences Other Announcement
Astec Lifesciences Ltd filed its quarterly shareholding pattern as of June 30, 2026. The filing lists promoters and public shareholders' stakes.
18:47 IST
NSE
Other Announcement
Astec Lifesciences Other Announcement
Astec LifeSciences submitted its Annual Secretarial Compliance Report for the financial year ended March 2026. The report details regulatory compliance status and past governance observations.
17:46 IST
BSE
Other Announcement
Astec Lifesciences Other Announcement
Astec LifeSciences notified shareholders regarding the mandatory transfer of unclaimed dividends and shares to the IEPF. This routine regulatory compliance follows the seven-year non-claim threshold.